146 related articles for article (PubMed ID: 34093789)
1. YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m
Hong L; Pu X; Gan H; Weng L; Zheng Q
J Cancer; 2021; 12(13):3809-3818. PubMed ID: 34093789
[TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.
Zhan L; Zhang J; Zhang JH; Liu XJ; Guo B; Chen JH; Tang ZH; Wang WY; Wang QY; Wei B; Cao YX
Biomark Res; 2023 Apr; 11(1):43. PubMed ID: 37085864
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
4. ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.
Pu X; Gu Z; Gu Z
J Cancer; 2020; 11(19):5612-5622. PubMed ID: 32913456
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
7. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
[TBL] [Abstract][Full Text] [Related]
8. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
[TBL] [Abstract][Full Text] [Related]
9. The biological function of m6A reader YTHDF2 and its role in human disease.
Wang JY; Lu AQ
Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
[TBL] [Abstract][Full Text] [Related]
10. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway.
Zhao T; Wang M; Zhao X; Weng S; Qian K; Shi K; Gu Y; Ying W; Qian X; Zhang Y
Front Oncol; 2022; 12():763341. PubMed ID: 35186724
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N
Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
[TBL] [Abstract][Full Text] [Related]
13. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
Hua Z; Wei R; Guo M; Lin Z; Yu X; Li X; Gu C; Yang Y
Oncogene; 2022 Mar; 41(10):1482-1491. PubMed ID: 35075244
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability.
Wang X; Zhang J; Wang Y
Am J Transl Res; 2019; 11(8):4909-4921. PubMed ID: 31497208
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
Front Oncol; 2020; 10():1566. PubMed ID: 33102202
[TBL] [Abstract][Full Text] [Related]
16. YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.
Wang C; Jeong K; Jiang H; Guo W; Gu C; Lu Y; Liang J
Am J Cancer Res; 2016; 6(5):996-1010. PubMed ID: 27293994
[TBL] [Abstract][Full Text] [Related]
17. Ythdf2-mediated STK11 mRNA decay supports myogenesis by inhibiting the AMPK/mTOR pathway.
Deng K; Liu Z; Li X; Ren C; Fan Y; Guo J; Li P; Deng M; Xue G; Yu X; Shi J; Zhang Y; Wang F
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127614. PubMed ID: 37884231
[TBL] [Abstract][Full Text] [Related]
18. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
19. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Chen X; Lu T; Ding M; Cai Y; Yu Z; Zhou X; Wang X
J Adv Res; 2023 Oct; ():. PubMed ID: 37865189
[TBL] [Abstract][Full Text] [Related]
20. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
